Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JINZHEN Granules for Mild to Moderate COVID-19
NCT05092503Phase 2Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical
- Start
- May 2022
- Primary completion
- May 2023
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
A Phase 2 trial of Jinzhen in coronavirus disease 2019 (COVID-19), sponsored by Jiangsu Kanion Pharmaceutical. Started May 2022; status: completed.
02
Drugs
Jinzhen
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05092503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05092503.